News
Press ReleaseCGT Catapult and Nakanoshima Qross to foster stronger relationships between the advanced therapies industry in the UK and Japan
Challenge Theme R&D spotlight: CGT Catapult HEK cell line developed to optimise rAAV vector productionRegulatory Round-up - April 2025INmune Bio partners with Cell and Gene Therapy Catapult to scale up CORDStrom™ manufacturing for commercial readinessRegulatory Round-up - March 2025Regulatory Round-up - February 2025Network established to identify opportunities for regulation to support innovation within advanced therapiesRegulatory Round-up - January 202570% increase in Phase I advanced therapy clinical trials in the UK in 2024Regulatory Round-up - December 2024Cell and Gene Therapy Catapult and UCL Researcher-in-Residence to develop a digital twin of CAR-T manufacturingRegulatory Round-up - November 2024Cell and gene therapy industry continues to expand manufacturing infrastructure in the UK